| Patient A Osteosarcoma | Units | Date | ||||||||||||||
| Test | 11/19/2004 | 1/11/2005 | 3/21/2005 | 6/22/2005 | 7/15/2005 | 9/19/2005 | 9/27/2005 | 11/22/2005 | 1/24/2006 | 3/21/2006 | ||||||
| WBC | 4800-10800 | 8100 | 6100 | 8100 | WBC | 5700 | 6300 | 6700 | ||||||||
| Lymphocyte | 960-4320 | 1800 | 1782 | 1891 | 2673 | Lymphocyte | 1596 | 1323 | 2020 | 1943 | ||||||
| % Lymphocyte | 20-40% | 22 | 31 | 33 | % Lymphocyte | 28 | 21 | 29 | ||||||||
| Total T Cell | 336-2376 | 756 | 1420 | 1405 | 2076 | Total T Cell | 1181 | 988 | 1535 | 1470 | ||||||
| % T Cell (T11, CD2) | 61-85% | 80 | 74 | 78 | % T Cell (T11, CD2) | 74 | 75 | 76 | 76 | |||||||
| Total T Helper Cell (T4) | 336-2376 | 820 | 813 | 1176 | Total T Helper Cell (T4) | 718 | 556 | 705 | 855 | |||||||
| % T Helper Cell (T4) | 35-55% | 42 | 46 | 43 | 44 | % T Helper Cell (T4) | 45 | 42 | 42 | 44 | ||||||
| Total Suppressor Cell | 192-1598 | 486 | 535 | 529 | 829 | Total Suppressor Cell | 431 | 397 | 563 | |||||||
| % Suppressor Cell (T8) | 20-37% | 27 | 30 | 28 | 31 | % Suppressor Cell (T8) | 27 | 30 | 31 | 29 | ||||||
| T Helper/T-Suppressor | 1-2.5 | 1.6 | 1.5 | 1.5 | 1.4 | T Helper/T-Suppressor | 1.7 | 1.4 | 1.35 | 1.5 | ||||||
| Total B Cell | 48-648 | 288 | 214 | 303 | 428 | Total B Cell | 255 | 172 | 253 | |||||||
| % B Cell (B1, CD20) | 006-29 | 16 | 12 | 16 | 16 | % B Cell (B1, CD20) | 16 | 13 | 13 | |||||||
| Total Natural Killer | 52-864 | 162 | 178 | 227 | 213 | Total Natural Killer | 192 | 186 | 253 | |||||||
| % Natural Killer Cells | 5.5-20% | 9 | 10 | 12 | 8 | % Natural Killer Cells | 12 | 14 | 13 | |||||||
| Total Immunocompetent | 14-216 | 18 | 38 | 53 | Total Immunocompetent | 48 | 40 | 39 | ||||||||
| % Immunocompetent-NKHT3+ | 1.5-5% | 1 | 2 | 2 | % Immunocompetent-NKHT3+ | 3 | 3 | 2 | ||||||||
| Total NKHT3 Negative | 38-648 | 160 | 189 | 160 | Total NKHT3 Negative | 144 | 146 | 214 | ||||||||
| % NKHT3 Negative | 4-15% | 9 | 10 | 6 | % NKHT3 Negative | 9 | 11 | 11 | ||||||||
| Total CD3+ CD26+ | 10-1944 | 838 | 813 | 1203 | Total CD3+ CD26+ | 718 | 609 | 816 | ||||||||
| % CD3+ CD26+ (TA1) | 1-45% | 47 | 43 | 45 | % CD3+ CD26+ (TA1) | 45 | 46 | 42 | ||||||||
| Total T3 (CD3) Positive C | 509-3413 | 1372 | 1381 | 2058 | Total T3 (CD3) Positive C | 1213 | 1006 | 1457 | ||||||||
| % T3 Positive Cells | 53-79% | 77 | 73 | 77 | % T3 Positive Cells | 76 | 76 | 75 | ||||||||
| Interleukin-2 Production | 0.13-1.10 | 0.1 | 0.1 | 1.4 | Interleukin-2 Production | 1.1 | 1 | <31.2 | ||||||||
| NK Cell Activity | 20-50 | 12.1 | 13.2 | 2.4 | NK Cell Activity | 4.45 | 40.9 | 24.6 | ||||||||
| NK Cell Activity/Cell | 5.1-10 | 6.8 | 5.8 | 1.1 | NK Cell Activity/Cell | 2.31 | 22 | 9.7 | ||||||||
| % Natural Killer Cells | 5.5-20% | 10 | 12 | 8 | % Natural Killer Cells | 12 | 14 | 13 | ||||||||
| % Immunocompetent-NKHT3+ | 1.5-5% | 1 | 2 | 2 | % Immunocompetent-NKHT3+ | 3 | 3 | 2 | ||||||||
| %NKHT3 Negative | 4-15% | 9 | 10 | 6 | %NKHT3 Negative | 9 | 11 | 11 | ||||||||
| Phytohemagglutinin | 75-125% | 114 | 115 | 33 | Phytohemagglutinin | 177 | 99 | 4 | ||||||||
| Concanavalin A | 75-125% | 85 | 34 | 52 | Concanavalin A | 121 | 120 | |||||||||
| Pokeweed Mitogen | 75-125% | 101 | 84 | 57 | Pokeweed Mitogen | 158 | 89 | 2 | ||||||||
| Lipopolysaccharide | 75-125% | 101 | 84 | 55 | Lipopolysaccharide | 161 | 89 | |||||||||
| Interleukin-2 Level | 0.13-1.10 | 0.1 | 0.1 | |||||||||||||
| Interferon Gamma (2-20pg/ml production) | 0.1-1.35 | 0.48 | 0.03 | 0.03 production | Interferon Gamma (2-20pg/ml production) | 5.1 | ||||||||||
| Interleukin-4 | 0.3-1.3 | 1.3 | 0.27 | |||||||||||||
| Interleukin-10 | 1.00-5.00 | 1 | 1 | |||||||||||||
| Interleukin-6 | 2.44 | 18.2 | <2.0 | |||||||||||||
| Interleukin-2 Receptor | 94-829.6U/ml | 456 | ||||||||||||||
| D-Dimer | <0.4ug/ml | 0.3 | <0.2 | |||||||||||||
| C-reactive Protein | 0-6 mg/L | 0.5 | ||||||||||||||
| 12/9/2004 | 2/10/2005 | 4/25/2005 | 7/15/2005 | 10/4/2005 | ||||||||||||
| Astr: 1 bid | 3 bid | dc | ||||||||||||||
| Reishi: 4 bid | x | x | dc | |||||||||||||
| Immuno: 4 bid | 4 tid | x | x | dc | ||||||||||||
| Eleu: 4 bid | x | Am Gin: 4qd | x | |||||||||||||
| Cel tinc: | Not taking | Celandine | 1t bid | x | ||||||||||||
| Brom: 5 bid | x | x | 5 bid | x | ||||||||||||
| Catalytic: 10bid | x | x | 7 bid | x | ||||||||||||
| Lakto: 6hs | x | x | dc | |||||||||||||
| Curcu: 1 bid | 4 bid | x | 2 q 3/4 hr 4 doses | x | ||||||||||||
| Vascu: 6bid | x | |||||||||||||||
| Modu: 3 bid | x | |||||||||||||||
| Cori: 3 bid | ||||||||||||||||
| Cord: 3 bid | 4 qd in am | x | ||||||||||||||
| Se: 2 | ||||||||||||||||
| Immun'a: 3pkt | ||||||||||||||||
| Limonene: 1/2-1t tid | 2 caps tid | |||||||||||||||
| Minor Bup: 1 tid | ||||||||||||||||
| Ultra potent: 1 T/d | ||||||||||||||||
| Melatonin: 20mg | ||||||||||||||||
| Ellagic: 6-10 caps | x | |||||||||||||||
| 11/18/2004 | 2/2/2005 | 6/22/2005 | 10/14/2005 | 2/6/2006 | ||||||||||||
| VEGF | 31-86 | <31 | 162 | 68 | 50 | |||||||||||
| IGF-1 | 114-492 | 193 | ||||||||||||||
| Immune Complex, C1q | <1.2 | |||||||||||||||
| IGF-Binding Protein-3 | 02-004 | 2.2 | ||||||||||||||
| Ceruloplasmin | 31 | |||||||||||||||
| Copper | 1214 | |||||||||||||||
| Hemoglobin | 15.1 | |||||||||||||||
| Hematocrit | 44 | |||||||||||||||
| 40tid, 60hs | ||||||||||||||||